Head of Computational Assisted Drug Design (CADD)
Full-timeSeniorComputational ChemistryDrug DiscoverySmall Molecule, BiologicsPhD
Market Rate — Chemists
25th
$60K
Median
$85K
75th
$113K
BLS 2024 data (national)
Description
We are seeking an innovative and experienced Head of CADD to lead our computational chemistry, AI/ML-driven molecular design efforts. You will oversee the integration of cutting-edge computational methods (e.g., molecular modeling, structure-based design, ligand-based design, AI/ML, and molecular dynamics) to accelerate the identification and optimization of novel therapeutics across multiple therapeutic areas. Key Responsibilities include defining and executing the CADD strategy to support small-molecule, biologics, or nucleotide-based drug discovery programs, collaborating with cross-functional teams, evaluating and implementing emerging computational tools, overseeing in silico drug design efforts, and staying abreast of advancements in CADD, AI/ML, and structural biology.
Requirements
PhD in Computational Chemistry, Bioinformatics, Pharmaceutical Sciences, or related fields. 10+ years in CADD (industry experience preferred), with a track record of contributing to drug discovery pipelines. Proven leadership experience managing high performance teams. Expertise in CADD tools: Schrödinger, MOE, OpenEye, GROMACS, Rosetta, etc. Proficiency in programming/scripting (Python, R, Perl) and ML frameworks (TensorFlow, PyTorch). Familiarity with HPC, cloud computing (AWS/GCP), and data visualization tools.
Sironax
BIOTECHNOLOGY
Therapies that address the root cause of age-related degenerative disease
LocationChina - Beijing
Employees51-200
Open Jobs12
Unknownneurodegenerative and age-related diseasesNeurodegenerative disease or inflammation-relatedBiotech/PharmaDrug Discovery
View Company Profile